EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice

Hong-Chao Sun, Pu-Ming Deng, Yuan Fu, Jin-Hua Deng, Rong-Hui Xie, Jing Huang, Meng Qi, Tuan-Yuan Shi

Frontiers in Cellular and Infection Microbiology · 12.07.2023 · 13

DOI: 10.3389/fcimb.2023.1209755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.07.2023. Verfasst von Hong-Chao Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Husbandry and Veterinary Medicine, Department of Animal Parasitology, Zhejiang Academy of Agricultural Sciences, Hangzhou, China. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis, Nanoparticles, Protozoan Vaccines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Toxoplasma gondii is an apicomplexan parasite that affects the health of humans and livestock, and an effective vaccine is urgently required. Nanoparticles can modulate and improve cellular and humoral immune responses.

Methods

In the current study, poly (D, L-lactic-co-glycolic acid) (PLGA) nanoparticles were used as a delivery system for the T. gondii dense granule antigens GRA12 and GRA7. BALB/c mice were injected with the vaccines and protective efficacy was evaluated.

Results

Mice immunized with PLGA+GRA12 exhibited significantly higher IgG, and a noticeable predominance of IgG2a over IgG1 was also observed. There was a 1.5-fold higher level of lymphocyte proliferation in PLGA+GRA12-injected mice compared to Alum+GRA12-immunized mice. Higher levels of IFN-g and IL-10 and a lower level of IL-4 were detected, indicating that Th1 and Th2 immune responses were induced but the predominant response was Th1. There were no significant differences between Alum+GRA7-immunized and PLGA+GRA7-immunized groups. Immunization with these four vaccines resulted in significantly reduced parasite loads, but they were lowest in PLGA+GRA12-immunized mice. The survival times of mice immunized with PLGA+GRA12 were also significantly longer than those of mice in the other vaccinated groups.

Conclusion

The current study indicated that T. gondii GRA12 recombinant protein encapsulated in PLGA nanoparticles is a promising vaccine against acute toxoplasmosis, but PLGA is almost useless for enhancing the immune response induced by T. gondii GRA7 recombinant protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaToxoplasmosisNanoparticlesProtozoan VaccinesHumansAnimalsMiceProtozoan ProteinsAntigens, ProtozoanRecombinant ProteinsLactic AcidMice, Inbred BALB CAntibodies, ProtozoanAlum Compounds

Stichwörter der Autor:innen

GRA12GRA7PLGAToxoplasma gondiinanoparticlesvaccine

Substanzen

Protozoan ProteinsAntigens, ProtozoanRecombinant ProteinsLactic AcidProtozoan VaccinesAntibodies, Protozoanaluminum sulfateAlum Compounds

Autor:innen und Institutionen

  • Institute of Animal Husbandry and Veterinary Medicine, Department of Animal Parasitology, Zhejiang Academy of Agricultural Sciences, Hangzhou, China.
  • Institute of Animal Science and Technology, Department of Animal Diseases Diagnosis and Control of Xinjiang Production & Construction Corps, Tarim University, Alar, China.
  • Department of Animal Epidemic Surveillance, Zhejiang Provincial Animal Disease Prevention and Control Center, Hangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, H. C., Deng, P. M., Fu, Y., Deng, J. H., Xie, R. H., Huang, J., Qi, M., & Shi, T. Y. (2023). Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1209755

Vancouver

Sun HC, Deng PM, Fu Y, Deng JH, Xie RH, Huang J, et al. Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1209755

BibTeX
@article{Sun2023,
  author = {Sun, Hong-Chao and Deng, Pu-Ming and Fu, Yuan and Deng, Jin-Hua and Xie, Rong-Hui and Huang, Jing and Qi, Meng and Shi, Tuan-Yuan},
  title = {Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1209755}
}
Kostenlos starten →